BRIDGE to liver health: implementation of a group telehealth psychoeducational program through shared medical appointments for MASLD management.

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a significantly costly and increasingly prevalent disease, with treatment focused on lifestyle intervention. Integrating education and behavioral health into clinical care offers opportunities to engage and empower patients to prevent progression of liver disease. We describe the design and implementation of Behavioral Resources and Intervention through Digital Group Education (BRIDGE), a 6-session group telehealth program led by advanced practice providers (APPs) in 90-min shared medical appointments (SMAs) with small groups of MASLD patients in an academic outpatient hepatology clinic.

Diagnosis and management of epiploic appendagitis: a single-institution 10-year experience.

<b>Introduction</b>: Epiploic appendagitis is known to be a benign and self-limiting process, yet optimal management is not well understood. Research focused on the efficacy of treatment in this rare condition may allow future patients diagnosed with epiploic appendagitis to be treated accordingly with the best evidence-based medical practice.<br/><b>Aim</b>: The aim of this study was to investigate the diagnosis, compare management options and follow up epiploic appendagitis.